Quantcast
Last updated on April 18, 2014 at 16:41 EDT

Latest Biomarker Stories

2014-02-06 08:27:18

ALBANY, New York, February 6, 2014 /PRNewswire/ -- According to a new market report published by Transparency Market Research "Molecular Diagnostics Market (PCR, Next Generation Sequencing, Microarray, Infectious diseases, Genetic disease, Oncology testing, Blood donor screening) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global molecular diagnostics market was valued at USD 4.3 billion in 2012 and is expected to grow at a CAGR of...

2014-02-05 16:27:30

Cleveland HeartLab CEO to present findings at Health & Wellness Congress CLEVELAND, Feb. 5, 2014 /PRNewswire/ -- Leading companies are increasingly recognizing that traditional fingerstick screening for glucose and lipids is proving inadequate when identifying near-term cardiovascular risk in employed populations, according to Jake Orville, CEO of Cleveland HeartLab (CHL). This position is supported by data from the American Heart Association, which has reported that fifty percent of...

2014-02-03 12:28:31

LONDON, Feb. 3, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Companion Biomarkers in Drug Development Companion biomarkers are diagnostic tests that are specifically linked to a therapeutic drug either during its development or in the clinic. This linkage can be an important component of the drug development process; alternatively, the companion biomarker can be useful in ameliorating the regulatory process for the drug, or acting as an aid to...

2014-01-30 12:28:48

International studies demonstrate importance of comprehensive tumor profiling for poor-prognosis cancer patients IRVING, Texas, Jan. 30, 2014 /PRNewswire/ -- Caris Life Sciences®, a leading biosciences company focused on fulfilling the promise of personalized medicine, will present two tumor profiling studies at the 2014 Genitourinary Cancers Symposium held this week in San Francisco, Calif. Through use of the company's comprehensive tumor profiling service, Caris Molecular Intelligence,...

2014-01-30 10:09:55

Researchers have developed a tool that allows caregivers to quickly and accurately predict the risk of death in children with septic shock – a systemic infection that damages vital organs and one of the leading causes of death among hospitalized children. Reporting their results Jan. 29 in PLOS ONE (published by the Public Library of Science), researchers say the study validates a tool that would let doctors decide much faster which severely sick children need to receive aggressive...

2014-01-29 20:23:47

DUBLIN, January 30, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/blxrzk/biomarkers ) has announced the addition of a new report "Biomarkers - Technologies, Markets and Companies" [http://www.researchandmarkets.com/research/blxrzk/biomarkers ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) This report follows the broad definition of a biomarker as a characteristic that can be objectively...

2014-01-29 12:27:40

CFAST Develops Processes to Accelerate Understanding of Alzheimer's disease and Asthma AUSTIN, Texas, Jan. 29, 2014 /PRNewswire-USNewswire/ -- The Clinical Data Interchange Standards Consortium (CDISC), Critical Path Institute (C-Path) and TransCelerate BioPharma Inc. ("TransCelerate") announced today that version 1.0 of the Asthma Therapeutic Area (TA) User Guide (UG) and version 2.0 of the Alzheimer's TAUG are now available for implementers on the CDISC website. These user guides...

2014-01-27 08:27:47

MOUNTAIN VIEW, Calif., Jan. 27, 2014 /PRNewswire/ -- Dr. Shinji Satomura, President, and Dr. Henry Wada, CSO of Wako Life Sciences, Inc., received an award from the Northern California Section of AACC for the scientific and technology contribution to clinical chemistry achieved by the development of the uTASWako i30 Immunoanalyzer. (Photo: http://photos.prnewswire.com/prnh/20140127/LA52677) (Logo: http://photos.prnewswire.com/prnh/20130729/LA53779LOGO-b) "Wako is happy to receive...

2014-01-24 23:20:30

Researchers say a new biomarker could help clinicians determine which mesothelioma patients are good candidates for surgery. Raleigh, NC (PRWEB) January 24, 2014 A new article published in the British Journal of Cancer and reported by Surviving Mesothelioma suggests that a glycoprotein called fibrinogen can help predict survival in patients with malignant mesothelioma. Fibrinogen is a soluble glycoprotein found in blood plasma and important for clotting. To test its relationship to...

2014-01-24 08:23:50

CASTLE ROCK, Colo., Jan. 24, 2014 /PRNewswire/ -- Venaxis, Inc. (Nasdaq: APPY), an in vitro diagnostic company focused on obtaining FDA clearance and commercializing its CE Marked APPY1 Test, a rapid, multiple biomarker-based assay for identifying patients that are at low risk for appendicitis, today announced completion of patient enrollment in its pivotal clinical study of the APPY1 Test in the United States. Venaxis expects to announce top-line data following the required...